| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |